comparemela.com

Latest Breaking News On - Allan macdougall - Page 2 : comparemela.com

Universal PropTech Inc Provides Update on SpotLight-19(C) - Designed to Detect COVID-19 in Under 20 Seconds and at a Cost of Approximately $1 Per Test

Universal PropTech Inc. Provides Update on SpotLight-19(C) - Designed to Detect COVID-19 in Under 20 Seconds and at a Cost of Approximately $1 Per Test UPI or the ISBRG ) has posted a number of updates on their website (www.isbrgcorp.com) regarding their SpotLight-19 © Technology including updating the expected COVID-19 detection time to under 20 seconds, at an approximate cost of $1 per COVID-19 test, an expanded list of solutions, and adding an additional advisor to the Advisory Board. ISBRG s SpotLight-19© technology leverages advancements in optics and artificial intelligence to define a state of COVID-19 infection. SpotLight-19© (which upon testing to establish specificity and sensitivity ISBRG intends to submit for regulatory approval) is designed to screen for a unique infectious state - within 20 seconds of scanning a fingertip with light. ISBRG is undertaking trials to determine SpotLight-19© s efficacy in detecting COVID-19, and if proven effective, will be

Universal PropTech Inc Provides Update on SpotLight-19 - Designed to Detect COVID-19 in Under 20 Seconds and at a Cost of Approximately $1 Per Test

Universal PropTech Inc Provides Update on SpotLight-19 - Designed to Detect COVID-19 in Under 20 Seconds and at a Cost of Approximately $1 Per Test
investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.

Universal PropTech Inc Invests in and Secures defined Agency Rights for ISBRG Corp s SpotLight-19(C) Technology Designed to Detect Covid-19 Non-Invasively in Under One Minute

Universal PropTech Inc. Invests in and Secures defined Agency Rights for ISBRG Corp. s SpotLight-19(C) Technology Designed to Detect Covid-19 Non-Invasively in Under One Minute UPI or the ISBRG ) for a minority interest, and secured agency rights to their SpotLight-19 © Technology. ISBRG is a data analytics company which has developed the SpotLight technology platform designed to generate comprehensive health care data non-invasively within seconds at a nominal incremental cost per test. SpotLight-19 © is non-invasive, and ISBRG is undertaking trials to determine efficacy in detecting Covid-19. In addition to its minority investment, UPI will act as the exclusive sales agent for the SpotLight-19

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.